Moleculin Biotech, Inc. (MBRX)
NASDAQ·Healthcare·Biotechnology
$0.52
-7.96%
Mkt Cap $2.78M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$0.52
-7.96%
Mkt Cap $2.78M
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —